We're making headlines

We're on a mission to transform medical research, for good. And people are taking notice.

Fierce Biotech: "Clinical trial matching platform raises $11M backed by Merck’s tech fund"

Global Corporate Venturing: "Merck Puts Money into Antidote"

Press Release: "Antidote Technologies Founder and CEO to Present at DPharm Conference"

Biotecnika: "Antidote Technologies Raises $11M In Funding Round Led By Merck, To Accelerate Development Of Its Trial Matching Platform"

LondonTechWatch: "These are the 15 London Startups That Raised the Most Capital in September 2017"

Biospectrum Asia: "Startup Antidote raises £11m"

Perficient: "How Merck & Facebook Are Pushing The Bounds Of Patient Recruitment"

MM&M: "How Pablo Graiver plans to solve the problem of clinical-trial recruitment"

TechWorld: "22 UK Healthtech Startups to Watch"

Press Release: "CaringKind Teams Up With Antidote Technologies to Address a Critical Problem: Connecting Alzheimer's Patients to Much-Needed Medical Research"

Press Contact
media-kit-cta